Tom Gaborski
Department Head
Tom Gaborski
Department Head
Education
BS, Cornell University; MS, Ph.D., University of Rochester
Bio
Tom Gaborski is a biomedical engineer, professor, and entrepreneur whose research lies at the intersection of biomaterials, microphysiological systems, extracellular vesicles, and vascular biology. His work focuses on understanding how engineered and biological interfaces regulate cell behavior, tissue-barrier function, and intercellular communication, with particular emphasis on endothelial barriers and inflammatory signaling.
As director of the NanoBio Materials Laboratory at RIT, Gaborski leads a multidisciplinary research program developing ultrathin and porous membrane technologies for microphysiological systems and extracellular-vesicle separation and analysis. His laboratory uses these engineered platforms to investigate fundamental questions in cell–material interactions, barrier formation and transport, and extracellular-vesicle interactions with vascular endothelium.
Gaborski’s research has been supported by multiple institutes and centers of the National Institutes of Health, as well as DARPA, the National Science Foundation, New York State, and industry partners. He is also Department Head of Biomedical Engineering at RIT and joined RIT in 2012 as a founding faculty member of the department.
Before returning to academia, Gaborski co-founded SiMPore, a nanomaterials company commercializing ultrathin membrane technologies. As the company’s president, he helped raise two rounds of investment and translate academic nanomembrane research into commercial products.
Select Scholarship
Peer-reviewed journal publications from the last 2 years:
63. Petersen KE, Alsudais M, Dehghani M, and Gaborski TR. Opportunities in next-generation porous membrane-based extracellular vesicle processing and applications. Critical Reviews in Biotechnology. 2026. https://doi.org/10.1080/07388551.2026.2699342
62. Alsudais M, Petersen KE, Hosseinfifakhr A, Frash LH, Gholizadeh S, Dehghani M, and Gaborski TR. Development of a PEGylated Parylene Nanopocket Membrane for the Capture and Release of Lipid Vesicles. Journal of Micromechanics and Micromachining 2026. https://doi.org/10.1088/1361-6439/ae9aa6
61. Dehghani M, Chai M, Talebloo N, Morrissey M, Larey A, Keselman P, Rana A, Islam M, Mayo M, Speidel J, Mukherjee P, Zhao Z, Haridas N, Marks P, Chon J, Kishimori E, Gaborski TR, Kim Y, Joshi D, Wu Y, Lu Y, Cheng R, Norton R, Zhong Y, Lahooti B, Trinidad C, Black E, Splan D, Pollard D, and Olszowy M. Bioprocess Design and Optimization of Extracellular Vesicles Derived from Mesenchymal Stromal Cells. ACS Nano 2026, 20, 21, 15032–15060.
60. Widom LP, Torabian P, Trempel MA, McCloskey MC, Michel LV, McGrath JL, and Gaborski TR. Bacterial extracellular vesicles indirectly destabilize a human stem cell–derived blood–brain barrier on-chip through pro-inflammatory stimulation of immune cells. Lab on a Chip. 2026. 26, 3327-3344.
59. Ceballos-Santa MC, TR Gaborski, Sanchez-Ortiz I, and Wuertz-Kozak K. A Step-by-Step Protocol for the Isolation of Aloe vera–Derived Extracellular Vesicles via Manual and Shear-Force Homogenization. Bio-protocol. 2026. 16(8): e5664.
58. Widom LP, Torabian P, Wojehowski AC, Ghaemmaghami D, Michel LV, and Gaborski TR. Antibiotics modulate Escherichia coli-derived bacterial extracellular vesicle production and their upregulation of ICAM-1 in human endothelial cells. Biology Open. 2026. 15(2): bio062476.
57. Trempel MA, Du Y, Widom LP, Reitz E, Feidler AM, Kasap P, Engelhardt B, Gaborski TR, Gelbard HA, Terrando N and McGrath JL. Pericytes repair engineered defects in the basement membrane to restore barrier integrity in an in vitro model of the blood-brain barrier. Materials Today Bio. 2025. 35: 102361.
56. Ceballos-Santa MC, TR Gaborski, Schulze S, Wuertz-Kozak K. Targeting Fibrotic Scars with Extracellular Vesicles Extracted from Mature Aloe vera: Enhanced Antioxidant, Anti-inflammatory, and Antifibrotic Activity through M2 Macrophage Polarization and Myofibroblasts Inhibition. bioRxiv. 2025. https://doi.org/10.1101/2025.06.17.660207
55. Torabian P, Singh N, Crawford J, Gonzalez G, Burgado N, Videva M, Miller A, Perdue J, Dinu M, Pietropaoli A, Gaborski TR, Michel LV. The effect of clinically relevant beta-lactam, aminoglycoside, and quinolone antibiotics on bacterial extracellular vesicle release from E. coli. International Journal of Antimicrobial Agents. 2025 (65):1, 107384.
Currently Teaching
In the News
-
August 27, 2024
RIT offers new master’s degrees in chemical engineering, biomedical engineering, and project management
The new engineering master’s degrees will serve to meet demands in increasing renewable energies, personalized healthcare technologies, and diagnostic system improvements. The project management MS allows students the ability to better specialize to their specific interests, giving them a competitive edge in their field of interest and making them more valuable to an employer.